Variant report
Variant | esv3350385 |
---|---|
Chromosome Location | chr12:60435485-60437583 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs538539133 | chr12:60436600-60436601 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs558564383 | chr12:60436612-60436613 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs527374261 | chr12:60436617-60436618 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs572084038 | chr12:60436643-60436644 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs187904197 | chr12:60436649-60436650 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs561188019 | chr12:60436688-60436689 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs138903248 | chr12:60436698-60436699 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs142813778 | chr12:60436758-60436759 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs78384085 | chr12:60436761-60436762 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs547557285 | chr12:60436805-60436806 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs567269566 | chr12:60436838-60436839 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs192483853 | chr12:60436880-60436881 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs532895455 | chr12:60436921-60436922 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs534031875 | chr12:60436930-60436931 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs552883130 | chr12:60436971-60436972 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs542881489 | chr12:60436975-60436976 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs146979655 | chr12:60437049-60437050 | Weak transcription Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
18 | rs549812523 | chr12:60437055-60437056 | Weak transcription Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
19 | rs113996575 | chr12:60437170-60437171 | Weak transcription Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
20 | rs116421970 | chr12:60437196-60437197 | Weak transcription Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
21 | rs567205421 | chr12:60437211-60437212 | Weak transcription Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
22 | rs529796485 | chr12:60437274-60437275 | Weak transcription Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
23 | rs549752158 | chr12:60437359-60437360 | Weak transcription Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
24 | rs569502083 | chr12:60437397-60437398 | Weak transcription Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
25 | rs538572051 | chr12:60437421-60437422 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs538948665 | chr12:60437446-60437447 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs115875688 | chr12:60437515-60437516 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs4539369 | chr12:60437535-60437536 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs183772016 | chr12:60437537-60437538 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Wilms tumour | 21544195 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Lung cancer | 20668451 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Malaria | 21533027 | CNVD |
Chronic lymphocytic leukemia | 22228453 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Chronic lymphocytic leukemia | 21670202 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Autism | 22495311 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Renal cell carcinoma | 18194544 | CNVD |
Breast cancer | 21949216 | CNVD |
Carcinoma ex pleomorphic adenoma | 18828159 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Cancer | 21637783 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Gastrointestinal stromal cancer | 20470368 | CNVD |
Adenoid cystic carcinoma | 17372589 | CNVD |
Lissencephaly | 21572526 | CNVD |
Lung cancer | 18438408 | CNVD |
Breast cancer | 19602461 | CNVD |
Breast cancer | 17899364 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Prostate cancer | 18632612 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
liposarcomas | 17372913 | CNVD |
Non-small cell lung cancer | 24170126 | CNVD |
Cancer | 16751803 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Breast cancer | 21785460 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Hodgkin''s lymphoma | 18179710 | CNVD |
Urothelial cell carcinoma | 18451213 | CNVD |
Melanoma | 18172304 | CNVD |
Glioblastoma multiforme | 21390271 | CNVD |
Cancer | 20164919 | CNVD |
Leukemia | 18628472 | CNVD |
Glioblastoma multiforme | 22291905 | CNVD |
Glioblastoma multiforme | 19435819 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Glaucoma | 21310917 | CNVD |
Breast cancer | 16272173 | CNVD |
Mental retardation | 19951919 | CNVD |
Glaucoma | 21447600 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Developmental delay | 21267005 | CNVD |
12q14 microdeletion syndrome | 21267005 | CNVD |
Developmental delay | 19277063 | CNVD |
Dwarfism | 19277063 | CNVD |
Fibroblasts | 20926602 | CNVD |
Follicular lymphoma | 18703704 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Glioblastoma multiforme | 20080666 | CNVD |
Medulloblastoma | 19270706 | CNVD |
Breast cancer | 17133270 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Gastrointestinal stromal cancer | 20877625 | CNVD |
Glioblastoma | 17090523 | CNVD |
Multiple myeloma | 16616336 | CNVD |
Lung cancer | 16773561 | CNVD |
Primary mediastinal b-cell lymphoma | 17728785 | CNVD |
Breast cancer | 21364760 | CNVD |
Melanoma | 20877625 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
Breast cancer | 22522925 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr12:60436600-60437000 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |
2 | chr12:60436800-60437000 | Enhancers | HUVEC | blood vessel |
3 | chr12:60437000-60437400 | Flanking Active TSS | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |
4 | chr12:60437000-60438000 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Female | -- |
5 | chr12:60437000-60442400 | Weak transcription | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
6 | chr12:60437200-60437600 | Enhancers | Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells | embryonic stem cell |
7 | chr12:60437400-60437800 | Enhancers | HUVEC | blood vessel |
8 | chr12:60437400-60438000 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |